from Reuters: Business News https://ift.tt/2HV5Pgy
Wednesday, April 3, 2019
Roche extends Spark offer after getting only 29 percent
Roche Holding has extended until May 2 its $4.3 billion offer for U.S. gene therapy specialist Spark Therapeutics, the Swiss drugmaker said after getting only 29.4 percent of Spark's shares in a tender originally due to end on Wednesday.
from Reuters: Business News https://ift.tt/2HV5Pgy
from Reuters: Business News https://ift.tt/2HV5Pgy
Related Posts:
Australia's Fairfax to share print costs with rival News Corp- Trade war puts the hoof into U.S. pig part exports to China
- Buffett's Berkshire Hathaway loosens policy on stock buybacks
- Canadian temporary tattoo start-up gets $10 million in funding
- CSX profit tops Wall St target on cost cuts, pricing power
0 comments:
Post a Comment